cladribine has been researched along with Astrocytoma, Grade IV in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gojkovic, Z; Hasholt, L; Joergensen, T; Knecht, W; Le Breton, C; Munch-Petersen, B; Piskur, J; Rozpedowska, E; Sandrini, MP; Willer, M | 1 |
| Grieb, P; Jagielski, J; Mossakowski, MJ; Ryba, M; Skierski, J | 1 |
| Grieb, P; Jagielski, J; Matyja, E; Mossakowski, MJ; Ryba, M | 1 |
3 other study(ies) available for cladribine and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Drosophila deoxyribonucleoside kinase mutants with enhanced ability to phosphorylate purine analogs.
Topics: Animals; Antimetabolites; Antineoplastic Agents; Cell Line, Tumor; Cladribine; Cytarabine; Directed Molecular Evolution; Drosophila melanogaster; Genes, Transgenic, Suicide; Genetic Therapy; Glioblastoma; Humans; Lethal Dose 50; Mutation; Neoplasms; Osteosarcoma; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Purines; Substrate Specificity; Transduction, Genetic; Vidarabine | 2007 |
DNA protein flow cytometry of dissociated cultures of human anaplastic gliomas. Pattern of proliferation and differentiation, and the effect of a new cytostatic drug cladribine (2-CdA).
Topics: Antineoplastic Agents; Astrocytoma; Brain; Cell Differentiation; Cell Movement; Cladribine; Culture Techniques; DNA, Neoplasm; Dose-Response Relationship, Drug; Flow Cytometry; Glioblastoma; Humans; Tumor Cells, Cultured | 1995 |
Mitochondrial damage following exposure of organotypic cultures of human malignant gliomas to 2-chloro- and 2-bromo-2'-deoxyadenosine.
Topics: Antineoplastic Agents; Astrocytoma; Cell Movement; Cladribine; Culture Techniques; Glioblastoma; Glioma; Humans; Mitochondria | 1996 |